Digital Therapeutics Alliance

Congratulations to #DTAMember HelloBetter for your permanent listing on #DiGA 🎉 https://lnkd.in/eXVWUQZj

📢 Urgent Update on Telehealth Coverage: Critical Provisions at Risk 📢 DTA is dedicated to supporting policies that enhance coverage and adoption of innovative healthcare solutions. While our primary focus is on advancing Digital Therapeutics (DTx), we recognize the vital role telehealth and virtual care play in expanding access to care, addressing clinician shortages, and improving health outcomes. Recent developments regarding the Continuing Resolution (CR) put essential telehealth provisions at risk. What initially seemed like a positive step forward now faces significant challenges. Political considerations unrelated to telehealth have placed critical coverage measures in jeopardy, including: ➡️ Two-year extension of Medicare telehealth flexibilities ➡️ First-dollar coverage for HDHP-HSAs ➡️ Five-year extension of the Acute Hospital Care at Home program ➡️ Expansion of the Medicare Diabetes Prevention Program to include virtual providers through 2030 These provisions are essential to ensuring equitable access to care for patients and maintaining healthcare innovation. If no action is taken, they could expire on January 1, 2025. At DTA, we are working alongside other stakeholders to strengthen a united front and advocate for Congress to protect these vital measures. Telehealth plays a pivotal role in closing gaps in access to care, supporting underserved communities, and mitigating the effects of clinician shortages. How You Can Help: 💪 Contact your members of Congress to emphasize the importance of preserving these critical telehealth measures. 💪 Frame policymakers as friends or potential allies in the effort to ensure access to care through telehealth. We believe that when technology is harnessed to its fullest potential, it can transform healthcare for all. By advocating together, we can ensure a future where telehealth remains a key pillar of care delivery. DTA remains committed to this cause, and we deeply appreciate your support. Let’s continue to fight for policies that improve healthcare access, equity, and innovation. #DTA #DTAUSPolicy #DigitalTherapeutics #DTx #digitalhealth #medtech

How might we as a DTx industry remove barriers for patient access and promote patient engagement? In this webinar, we will introduce the Patient Odyssey resource—designed to guide DTx companies through the complexities of engaging patients at every stage of their healthcare experience. From initial awareness to sustained use, the Patient Odyssey framework helps DTx providers identify key touchpoints, anticipate patient needs, and optimize engagement strategies for maximum impact. Join us to explore how understanding the patient journey can drive successful adoption, enhance patient experience, and ultimately improve health outcomes. Whether you're a DTx developer, healthcare provider, or industry stakeholder, this session will provide actionable insights to enhance your approach to patient engagement in the rapidly evolving world of digital therapeutics. Lani Reilly, OTR/L Heather Manning Tim Campellone, PhD Floreo Woebot Health #PatientEngagement #DTx #DigitalTherapeutics #DTAEvents

📣 New Blog: 2024 Digital Therapeutics Alliance Summit: A Patient Perspective 📣 Angela White, a patient advocate, attended the 2024 Digital Therapeutics Alliance Summit and shares her experience in our latest blog. From listening to policymakers and payers discuss the future of DTx, to contributing to workshops on clinician and patient education, Angela highlights the power of collaboration in advancing digital therapeutics. She also reflects on the potential of DTx to transform care for chronic conditions like multiple sclerosis and emphasizes the importance of patient voices in shaping this innovative field. 👉 Read Angela's full blog here: https://lnkd.in/gUDSbScg Thank you to Savvy Cooperative and all of the patient advocates who bring invaluable insights to these conversations! #DigitalTherapeutics #PatientAdvocate #2024DTASummit #DTx

Thank you to our expert group of panelists, Marty Culjat (EVERSANA), Ridwana Isla, PMP (Boehringer Ingelheim), Steven Lee (Click Therapeutics, Inc.), and Michal Tsur (Remepy) for sharing their insights during our webinar, “Optimizing the Patient Experience with PDURS.” From exploring the role of Prescription Drug Use Related Software (PDURS) in real-time treatment management to discussing its impact on patient safety and healthcare challenges, this session offered valuable perspectives on the future of drug-software combinations. 🎥 Missed it live? Watch the full recording here: https://lnkd.in/eNFNDPTb Thank you to everyone who joined us, and stay tuned for more DTA webinars! https://lnkd.in/gFKv37Cd #DTAEvents #DTx #DigitalTherapeutics #DigitalTherapeuticsAlliance #PDURS Andy Molnar

A big thank you to our event sponsor, ClearView Healthcare Partners, for sponsoring the DTA Reimbursement Intensive next month! About ClearView: ClearView was founded on the principles of clarity, quality, and collaboration. We believe these principles yield better project experiences, decision-making, and business outcomes. Our differentiated depth of content expertise enables us to understand and communicate around new discovery, development, and commercial opportunities with rigor and precision – and to challenge clinical and commercial clients with new ways of thinking. We serve global life science companies of all sizes from offices across the United States and Europe. This event is currently sold out, but we are offering a waitlist for any last minute openings and future intensives. Join the waitlist: https://lnkd.in/giNv4UP6

Thank you to our panelists Carrie Nixon, Ronald S. Moser, and Adam Malone, for an insightful conversion around privacy and security considerations that are key to the successful development and implementation of DTx products. We chatted about... 🔷 Key international and national security standards for digital therapeutics 🔷 The impact of regulatory compliance on risk mitigation 🔷 Key privacy regulations for digital therapeutics 🔷 And effective privacy governance and consent processes Stay up to date on DTA's upcoming events: https://lnkd.in/gFKv37Cd

One day left to register for "Optimizing the Patient Experience with PDURS"! Join us tomorrow to discuss: - An overview of PDURS - How PDURS influences patient safety and health outcomes - How PDURS can aid in solving current challenges in the healthcare system - What the Digital Therapeutics Alliance is doing for PDURS Andy Molnar Marty Culjat Ridwana Isla, PMP Steven L. Michal Tsur

Have you seen the white paper by DTA member, IDEA Pharma | From R&D to RxD, A Review of Four Promising Digital Health Solutions in Oncology: Digital Therapeutics, Remote Monitoring, Clinical Decision Support and Wellness Applications? Read the full paper: https://lnkd.in/eS2wz-gh #IDEAPharma #DTA #DigitalTherapeuticsAlliance #DigitalTherapeutics #DigitalHealth #DigitalHealthSolutions #MedTech #HealthTech

One week until Digital Therapeutics Alliance is hosting "Optimizing the Patient Experience with PDURS"! Register now to join us on December 12: https://lnkd.in/giQEF9Jk